Literature DB >> 1287639

Mucolipidosis type IV: accumulation of phospholipids and gangliosides in cultured amniotic cells. A tool for prenatal diagnosis.

M Zeigler1, R Bargal, V Suri, B Meidan, G Bach.   

Abstract

Cultured amniotic fluid cells from two mucolipidosis type IV (MLIV)-affected fetuses demonstrated accumulation of phospholipids and gangliosides when compared with normal controls. Like cultured skin fibroblasts from MLIV patients, cultured amniotic cells from the affected fetuses accumulated primarily lyso phospholipids and this could be demonstrated by radioactive labelling with appropriate precursors, either inorganic phosphate or oleic acid. Furthermore, like cultured skin fibroblasts, there was significant retention of exogenously supplied GD1A ganglioside in the affected amniotic cells. This storage was previously demonstrated to be unique to MLIV and thus can be used at present as a specific procedure for prenatal diagnosis of MLIV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287639     DOI: 10.1002/pd.1970121209

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

1.  G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts.

Authors:  S Raghavan; E Leshinsky; E H Kolodny
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Mucolipidosis type IV: abnormal transport of lipids to lysosomes.

Authors:  R Bargal; G Bach
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

3.  Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis.

Authors:  S M Jansen; J E Groener; W Bax; B J Poorthuis
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

4.  Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis.

Authors:  Sebastian Treusch; Sarah Knuth; Susan A Slaugenhaupt; Ehud Goldin; Barth D Grant; Hanna Fares
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

5.  Mucolipidosis IV fibroblasts synthesize normal amounts of hyaluronic acid.

Authors:  E Goldin; Y Imai; C R Kaneski; P G Pentchev; R O Brady; V C Hascall
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Systematic screens for proteins that interact with the mucolipidosis type IV protein TRPML1.

Authors:  Ellen Spooner; Brooke M McLaughlin; Talya Lepow; Tyler A Durns; Justin Randall; Cameron Upchurch; Katherine Miller; Erin M Campbell; Hanna Fares
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 7.  Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.

Authors:  Aleksandra Jezela-Stanek; Elżbieta Ciara; Karolina M Stepien
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.